1. Home
  2. VHC vs RFL Comparison

VHC vs RFL Comparison

Compare VHC & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirnetX Holding Corp

VHC

VirnetX Holding Corp

HOLD

Current Price

$16.33

Market Cap

79.2M

Sector

Miscellaneous

ML Signal

HOLD

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$1.28

Market Cap

61.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VHC
RFL
Founded
2005
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Real Estate
Sector
Miscellaneous
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
79.2M
61.1M
IPO Year
2008
2017

Fundamental Metrics

Financial Performance
Metric
VHC
RFL
Price
$16.33
$1.28
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.9K
92.9K
Earning Date
01-01-0001
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
35.17
28.28
EPS
N/A
N/A
Revenue
$5,000.00
$917,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
43.96
52 Week Low
$6.60
$1.12
52 Week High
$29.00
$3.19

Technical Indicators

Market Signals
Indicator
VHC
RFL
Relative Strength Index (RSI) 45.92 48.08
Support Level $15.94 $1.15
Resistance Level $18.09 $1.38
Average True Range (ATR) 1.50 0.12
MACD 0.15 -0.00
Stochastic Oscillator 47.28 30.00

Price Performance

Historical Comparison
VHC
RFL

About VHC VirnetX Holding Corp

VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: